Brind.
  1. OCS technology is cited as a key factor driving the growth of Transmedics.

OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.

5 reports, 1 independent Updated Aug 5
Gone quiet
Reports
5
Developments
1
Repetition
80%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Motley FoolWhy TransMedics Stock Is Skyrocketing Today TransMedics grew sales by 38% during the second quarter and saw its profit margins double compared to last year. Despite this, there may still be room for
  • Motley FoolTransMedics Sees Its Earnings Soar In its latest quarter, TransMedics reported solid gains in revenue and saw net income nearly triple from year-ago levels. TransMedics increased its full-year 2025 s
  • Unknown outlet
2 more outlets ran the same wire story